← All companies

PRQR

ProQR Therapeutics N.V.

PRQR Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.71

-0.07 -3.93%

Key statistics

from XBRL data in SEC filings

Market cap

$180M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$1.33 – $3.10

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jun 26, 2026 6-K FORM 6-K Jun 25, 2026 6-K FORM 6-K Jun 2, 2026 6-K May 12, 2026 6-K FORM 6-K May 12, 2026 6-K FORM 6-K May 4, 2026 6-K FORM 6-K Apr 30, 2026 6-K FORM 6-K Apr 8, 2026 6-K FORM 6-K Apr 8, 2026 6-K FORM 6-K Mar 25, 2026 20-F Mar 12, 2026 6-K FORM 6-K Mar 12, 2026 6-K FORM 6-K Feb 9, 2026 6-K FORM 6-K Jan 8, 2026 6-K Nov 6, 2025 6-K FORM 6-K Nov 3, 2025 6-K FORM 6-K Oct 20, 2025 6-K Aug 7, 2025 6-K FORM 6-K Jun 26, 2025 6-K FORM 6-K Jun 3, 2025 6-K May 8, 2025 6-K FORM 6-K May 1, 2025 6-K FORM 6-K Apr 14, 2025 20-F Mar 13, 2025 6-K FORM 6-K Mar 13, 2025 6-K/A FORM 6-K/A Dec 12, 2024 6-K FORM 6-K Dec 11, 2024 6-K FORM 6-K Dec 11, 2024 6-K FORM 6-K Dec 10, 2024 6-K FORM 6-K Dec 5, 2024 6-K Nov 7, 2024 6-K FORM 6-K Oct 25, 2024 6-K Aug 8, 2024 6-K FORM 6-K May 22, 2024 6-K May 9, 2024 6-K FORM 6-K May 8, 2024 6-K FORM 6-K Apr 23, 2024 6-K FORM 6-K Apr 19, 2024 20-F Mar 13, 2024 6-K FORM 6-K Mar 13, 2024